The prediction of interferon treatment effects based on time series microarray gene expression profiles

Area of Science:

• Genomics
• Bioinformatics
• Translational Medicine

Background:

• Disease status correlates with specific gene expression profiles.
• Hepatitis C Virus (HCV) infection requires effective treatment strategies.
• Interferon and ribavirin are common therapies for HCV.

Purpose of the Study:

• To develop a time-dependent diagnostic model for predicting treatment response in HCV patients.
• To utilize time series gene expression profiles for predicting outcomes of interferon and ribavirin therapy.
• To identify potential biomarkers for treatment response.

Main Methods:

• Analysis of time series microarray gene expression data from HCV patients undergoing interferon and ribavirin therapy.
• Construction of a C4.5 decision tree model incorporating pre-treatment and on-treatment gene expression.
• Application of a voting method combining statistical tests to identify differentially expressed genes.
• Leave-one-out cross-validation for model performance evaluation.

Main Results:

• The diagnostic model accurately predicted treatment effects in Caucasian American patients at early time points.
• Achieved 85.7% prediction accuracy for African-American patients.
• Identified thirty potential biomarkers associated with treatment response.

Conclusions:

• Time series gene expression profiling offers a viable strategy for predicting treatment efficacy in HCV.
• The developed model can aid in optimizing interferon and ribavirin therapy decisions.
• This approach may be applicable to improving treatment strategies for other chronic diseases.